The Consultation will aim to contribute to engaging multi-sectoral partners reach consensus on priority areas and key policy strategies to mainstreaming migrant health and enabling an environment for meaningful policy change. The activities under this project will provide support and coordination to the Scientific Committee and the technical consultants, who will contribute to the completion of the background papers, which will guide the discussions of the Consultation, and final Report.

As of April 1, 2017, the IRCC introduces a new reimbursement scheme for health assessment of Canada-bound refugees as a part of Interim Federal Health Program (IFHP), which until now has been providing temporary coverage of health care benefits to refugees in Canada.

This project is an historic partnership between the International Organization for Migration (IOM), the Centers for Disease Control and Prevention (CDC) and the Bureau of Population, Refugees and Migration (PRM) to introduce vaccinations early in the US Resettlement Program (USRP) process.

At the request of the Government of the United Kingdom, IOM implements the Tuberculosis (TB) Detection Programme for visa applicants who intend to stay in the UK for a period of 6 months or longer. The main purpose of the programme is to address public health concerns regarding the spread of infectious tuberculosis in the UK by preventing the entry of people suffering from active TB until they have been successfully treated, as well as to facilitate access to diagnostics and referrals for treatment in the migrants’ countries of origin.

At the request of the Government of Canada, IOM carries out migration health assessment and DNA sample collection services for immigration self-payer applicants referred by the local Canadian High Commissions, in accordance with the Canadian government’s instructions for medical and radiological examination of Canadian visa applicants.